Abstract submission for ESHG 2024 is now open.
The Abstract submission deadline is Thursday, February 1, 2024 at 23:59 hrs CET.
Notifications about the outcome of the abstract assessment will be sent to all presenting authors by March 21, 2024.
Important Information on the Selection Process
All abstracts are peer-reviewed and ranked on the basis of scientific merit by experts in the category selected. The Scientific Programme Committee uses these rankings to develop the scientific sessions. Abstracts are assigned to either plenary, concurrent or poster sessions.
The ESHG 2024 conference has 3 types of acceptance for submissions:
- Oral Presentation: Presenter must attend the in-person conference to present their work as an in-person oral presentation. In addition, the presentation will be live streamed, recorded and made available as on-demand content on the virtual conference platform.
- Hybrid Poster: Presenter must attend the in-person conference to present their poster during one of the “Poster Viewing with Author” sessions. In addition, the presenter must upload a PDF version of their poster to the virtual conference platform.
- E-Poster: Presenter must present their work virtually by uploading their poster as a PDF document to the virtual platform. Presenter must register for the conference and can decide to either attend in-person or online.
The format of acceptance will depend on the scoring result of the respective abstract and your selected preferred option.
Submitters will be informed about the format of their abstract in their e-mail acceptance notification.
- The presentation at the conference (in-person or online) is the condition for the publication of the abstract in the electronic supplement of the European Journal of Human Genetics. Accepted abstracts will be published in the Journal after the conference.
- By submitting an abstract submitters agree that their personal data are being saved and used by the organiser in order to process the submission, enable the presentation at the conference and the publication of the abstract in the Journal.
- You may be presenting author of only one paper, but co-author of any number of abstracts.
- Multiple submissions with identical presenting authors will be automatically rejected.
- Identical submissions from different first authors will also be automatically rejected.
- Abstracts containing no results or structure will be rejected.
Abstracts considered to be of particular interest to the media may be selected for press releases. In this case, you will be contacted by the Society’s media consultant. Please note that once your work has been published it cannot be considered as a candidate for a press release.
ESHG Abstract Submission Topics 2024 – Where does my abstract fit?
The enormous achievements in the field of Human Genetics during the last years are changing not only our understanding of genetics of diseases but also our research approaches and daily work in the clinic. Due to these new developments and insights, the traditional borders between clinical genetics, cytogenetics and molecular genetics as well as between research into monogenic and complex disorders are getting blurry. The Scientific Programme Committee (SPC) of the ESHG decided to reflect these changes in its updated abstract submission categories.
Where does my abstract fit?
The disease categories (1-12) are meant to cover all aspects of the specific disorders indicated, i. e. clinically, cytogenetically and molecularly, ranging from basic research to diagnosis and treatment.
Topic 13. Multiple Malformation/Anomalies Syndromes is meant for abstracts related to complex syndromes and cytogenetic disorders with multiple symptoms.
Topic 14. Cytogenetics, Genome Variation and Architecture is meant for abstracts discussing genomic variation and genome structure not necessarily related to a specific phenotype (e. g. splicing mechanisms, origin of ring chromosomes etc.) and abstracts related to chromosome and genome architecture studies.
Topic 15. Diagnostic Improvements and Quality Control is dedicated to general aspects of technical approaches and quality control in genetic diagnostics and research.
Topic 16. Bioinformatics, Machine Learning and Statistical Methods is dedicated to abstracts related to bioinformatics, machine learning and statistical approaches in genomics and other -omics.
Topic 17. Large Scale Association Studies (GWAS) is dedicated to abstracts presenting the genetics of complex diseases and traits, GWAS results for rare and common variation and functional follow-up studies from GWAS.
Topic 18. Genetic Epidemiology and Pharmacogenomics is meant for abstracts studying the role of genomics and other -omics to personalized medicine, epidemiology, public health, and drug response, including mendelian randomization studies.
Topic 19. Population Genetics and Evolutionary Genetics is meant for abstracts in population genetics and evolutionary genetics.
Topic 20. Functional Genomics is for abstracts dedicated to study the biology and function of the genome, including epigenetic.
Topic 21. New Technologies shall draw attention to brand new concepts or new genomic technologies and the evaluation of their potential.
Topic 22. Treatments for Genetic Disorders is for abstracts related to novel therapeutic opportunities for genetic disorders.
Topic 23. Genetic Counselling / Services / Education covers general issues of genetic counselling, education and public services.
Topic 24. Ethical, Legal and Psychosocial Aspects in Genetics is meant for abstracts discussing psychological, ethical and legal issues of genetics.
We hope that these updated categories will enhance communication between researchers using different approaches. We are also typically using them to facilitate the selection of expert reviewers.
01. Cancer Genetics
02. Reproductive Genetics
03. Prenatal Genetics
04. Sensory Disorders (Eye, Ear, Pain)
05. Internal Organs & Endocrinology (Lung, Kidney, Liver, Gastrointestinal)
06. Skeletal, Connetive Tissue, Ectodermal and Skin Disorders
07. Cardiovascular Disorders
08. Metabolic and Mitochondrial Disorders
09. Immunology and Hematopoietic System
10. Intellectual Disability
11. Neurogenetic and Psychiatric Disorders
12. Neuromuscular Disorders
13. Multiple Malformation/Anomalies Syndromes
14. Cytogenetics, Genome Variation and Architecture
15. Diagnostic Improvements and Quality Control
16. Bioinformatics, Machine Learning and Statistical Methods
17. Large Scale Association Studies (GWAS)
18. Genetic Epidemiology and Pharmacogenomics
19. Population Genetics and Evolutionary Genetics
20. Functional Genomics
21. New Technologies
22. Treatments for Genetic Disorders
23. Genetic Counselling / Services / Education
24. Ethical, Legal and Psychosocial Aspects in Genetics